Deferiprone

去铁酮

Report date: 2026/03/19 20:00:18
NME

Base Information

Drug NameDeferiprone
Drug Alias NameDimethyl hydroxypyridone除铁酮DeferumFerriproxKelfer +[18] 
ClassificationSmall molecules > Polymers and chelators
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsCognitive DysfunctionHemosiderosisIron Overload +[15] 
Global Approved IndicationsIron Overloadbeta-ThalassemiaThalassemia
Approved Indications in ChinaIron OverloadThalassemia
Original Approved Country/TerritoryEU
Original Approved Date1999/08/25
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesApotex
China Registration ClassN/A

Develop Information

Active CompaniesThe Florey Institute Of Neuroscience And Mental HealthChiesi Usa IncApotex +[6] 
Inactive CompaniesUT Health San AntonioAin Shams UniversityCormedix Inc +[4] 
Active IndicationsCognitive DysfunctionHemosiderosisIron Overload +[9] 
Inactive IndicationsAnemia, Sickle CellAcute Kidney InjuryFriedreich Ataxia +[6] 

Other Information

ATC CodeV03AC02
Related LinksWikipediaDrugBankKEGG